BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26219913)

  • 21. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
    Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY
    J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.
    Pignochino Y; Dell'Aglio C; Inghilleri S; Zorzetto M; Basiricò M; Capozzi F; Canta M; Piloni D; Cemmi F; Sangiolo D; Gammaitoni L; Soster M; Marchiò S; Pozzi E; Morbini P; Luisetti M; Aglietta M; Grignani G; Stella GM
    BMC Cancer; 2015 May; 15():374. PubMed ID: 25952930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.
    Bongard RD; Lindemer BJ; Krenz GS; Merker MP
    Free Radic Biol Med; 2009 Jan; 46(1):25-32. PubMed ID: 18848878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotinamide, a glucose-6-phosphate dehydrogenase non-competitive mixed inhibitor, modifies redox balance and lipid accumulation in 3T3-L1 cells.
    Torres-Ramírez N; Baiza-Gutman LA; García-Macedo R; Ortega-Camarillo C; Contreras-Ramos A; Medina-Navarro R; Cruz M; Ibáñez-Hernández MÁ; Díaz-Flores M
    Life Sci; 2013 Dec; 93(25-26):975-85. PubMed ID: 24184296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
    Dong YB; Yang HL; Elliott MJ; McMasters KM
    Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes.
    Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
    Anticancer Res; 2017 Jan; 37(1):149-159. PubMed ID: 28011485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress in hypercholesterolemic LDL (low-density lipoprotein) receptor knockout mice is associated with low content of mitochondrial NADP-linked substrates and is partially reversed by citrate replacement.
    Paim BA; Velho JA; Castilho RF; Oliveira HC; Vercesi AE
    Free Radic Biol Med; 2008 Feb; 44(3):444-51. PubMed ID: 17991444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2.
    Koch T; Seifert A; Wu DF; Rankovic M; Kraus J; Börner C; Brandenburg LO; Schröder H; Höllt V
    J Neurochem; 2009 Aug; 110(4):1288-96. PubMed ID: 19519662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental ontogeny of NAD+ kinase in the rat conceptus.
    Akella SS; Harris C
    Toxicol Appl Pharmacol; 2001 Jan; 170(2):124-9. PubMed ID: 11162776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.
    Mu W; Hu C; Zhang H; Qu Z; Cen J; Qiu Z; Li C; Ren H; Li Y; He X; Shi X; Hui L
    Cell Res; 2015 Apr; 25(4):477-95. PubMed ID: 25698578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers.
    Li G; Yu K; Li F; Xu K; Li J; He S; Cao S; Tan G
    J Ethnopharmacol; 2014 Apr; 153(2):521-30. PubMed ID: 24631140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells.
    Cheng Q; Shi H; Wang H; Min Y; Wang J; Liu Y
    Chem Commun (Camb); 2014 Jul; 50(56):7427-30. PubMed ID: 24777030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action.
    Haynes RK; Cheu KW; Chan HW; Wong HN; Li KY; Tang MM; Chen MJ; Guo ZF; Guo ZH; Sinniah K; Witte AB; Coghi P; Monti D
    ChemMedChem; 2012 Dec; 7(12):2204-26. PubMed ID: 23112085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice.
    Lo J; Lau EY; Ching RH; Cheng BY; Ma MK; Ng IO; Lee TK
    Hepatology; 2015 Aug; 62(2):534-45. PubMed ID: 25902734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo.
    Zhang H; Li Z; Wang K
    Oncol Rep; 2014 Apr; 31(4):1954-60. PubMed ID: 24549815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In cancer, all roads lead to NADPH.
    Rather GM; Pramono AA; Szekely Z; Bertino JR; Tedeschi PM
    Pharmacol Ther; 2021 Oct; 226():107864. PubMed ID: 33894275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression.
    Terranova-Barberio M; Roca MS; Zotti AI; Leone A; Bruzzese F; Vitagliano C; Scogliamiglio G; Russo D; D'Angelo G; Franco R; Budillon A; Di Gennaro E
    Oncotarget; 2016 Feb; 7(7):7715-31. PubMed ID: 26735339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.
    Wu JR; Hu CT; You RI; Pan SM; Cheng CC; Lee MC; Wu CC; Chang YJ; Lin SC; Chen CS; Lin TY; Wu WS
    Oncotarget; 2015 Oct; 6(32):32526-44. PubMed ID: 26416447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer.
    Chen XX; Xie FF; Zhu XJ; Lin F; Pan SS; Gong LH; Qiu JG; Zhang WJ; Jiang QW; Mei XL; Xue YQ; Qin WM; Shi Z; Yan XJ
    Oncotarget; 2015 Jun; 6(17):14926-39. PubMed ID: 25962959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of cytosolic NADP+-dependent isocitrate dehydrogenase gene enhances ethanol-induced toxicity in HepG2 cells.
    Yang ES; Lee SM; Park JW
    Arch Pharm Res; 2010 Jul; 33(7):1065-71. PubMed ID: 20661717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.